170 related articles for article (PubMed ID: 28466688)
1. The Role of Peroxisome Proliferator-Activated Receptor γ in Mediating Cardioprotection Against Ischemia/Reperfusion Injury.
Zhong CB; Chen X; Zhou XY; Wang XB
J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):46-56. PubMed ID: 28466688
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hexadecyl Azelaoyl Phosphatidylcholine on Cardiomyocyte Apoptosis in Myocardial Ischemia-Reperfusion Injury: A Hypothesis.
Feng L; Liu W; Yang J; Wang Q; Wen S
Med Sci Monit; 2018 Apr; 24():2661-2667. PubMed ID: 29706617
[TBL] [Abstract][Full Text] [Related]
3. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.
Intachai K; C Chattipakorn S; Chattipakorn N; Shinlapawittayatorn K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134547
[TBL] [Abstract][Full Text] [Related]
5. Effects of microRNA-292-5p on myocardial ischemia-reperfusion injury through the peroxisome proliferator-activated receptor-α/-γ signaling pathway.
Zhu ZD; Ye JY; Niu H; Ma YM; Fu XM; Xia ZH; Zhang X
Gene Ther; 2018 Jun; 25(3):234-248. PubMed ID: 29670247
[TBL] [Abstract][Full Text] [Related]
6. Conditional deletion of cardiomyocyte peroxisome proliferator-activated receptor γ enhances myocardial ischemia-reperfusion injury in mice.
Hobson MJ; Hake PW; O'Connor M; Schulte C; Moore V; James JM; Piraino G; Zingarelli B
Shock; 2014 Jan; 41(1):40-7. PubMed ID: 24089001
[TBL] [Abstract][Full Text] [Related]
7. KLF5 overexpression attenuates cardiomyocyte inflammation induced by oxygen-glucose deprivation/reperfusion through the PPARγ/PGC-1α/TNF-α signaling pathway.
Li Y; Li J; Hou Z; Yu Y; Yu B
Biomed Pharmacother; 2016 Dec; 84():940-946. PubMed ID: 27764756
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide induces peroxisome proliferator activated receptor γ during cardiac ischemia-reperfusion in swine heart.
Suzuki T; Saiki Y; Horii A; Fukushige S; Kawamoto S; Adachi O; Akiyama M; Ito K; Masaki N; Saiki Y
Gen Thorac Cardiovasc Surg; 2017 Feb; 65(2):85-95. PubMed ID: 27510704
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo.
Lotz C; Lazariotto M; Redel A; Smul TM; Stumpner J; Blomeyer C; Tischer-Zeitz T; Schmidt J; Pociej J; Roewer N; Kehl F; Lange M
Exp Biol Med (Maywood); 2011 Jan; 236(1):113-22. PubMed ID: 21163821
[TBL] [Abstract][Full Text] [Related]
10. Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2.
Katsumata Y; Shinmura K; Sugiura Y; Tohyama S; Matsuhashi T; Ito H; Yan X; Ito K; Yuasa S; Ieda M; Urade Y; Suematsu M; Fukuda K; Sano M
Hypertension; 2014 Jan; 63(1):80-7. PubMed ID: 24101662
[TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
12. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
13. PPARγ Agonist Ameliorates the Impaired Fluidity of the Myocardial Cell Membrane and Cardiac Injury in Hypercholesterolemic Rats.
Wu Y; Tan X; Tian J; Liu X; Wang Y; Zhao H; Yan Z; Liu H; Ma X
Cardiovasc Toxicol; 2017 Jan; 17(1):25-34. PubMed ID: 26679939
[TBL] [Abstract][Full Text] [Related]
14. Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.
Qian J; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y
Cardiovasc Drugs Ther; 2016 Apr; 30(2):129-41. PubMed ID: 26861490
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin relieves myocardial ischemia/reperfusion injury by upregulating PPAR‑γ and UCP2.
Wang L; Lin R; Guo L; Hong M
Mol Med Rep; 2018 Jul; 18(1):789-798. PubMed ID: 29845235
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-128 inhibition attenuates myocardial ischemia/reperfusion injury-induced cardiomyocyte apoptosis by the targeted activation of peroxisome proliferator-activated receptor gamma.
Zeng XC; Li L; Wen H; Bi Q
Mol Med Rep; 2016 Jul; 14(1):129-36. PubMed ID: 27150726
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
19. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.
Yin Y; Guan Y; Duan J; Wei G; Zhu Y; Quan W; Guo C; Zhou D; Wang Y; Xi M; Wen A
Eur J Pharmacol; 2013 Jan; 699(1-3):219-26. PubMed ID: 23200898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
